Core Viewpoint - Rosen Law Firm is encouraging investors of Cepton, Inc. to secure legal counsel before the December 8, 2025 deadline for a securities class action related to the company's stock transactions during the specified class period [1][2]. Group 1: Class Action Details - The class period for the Cepton securities class action is from July 29, 2024, to January 6, 2025, inclusive [1]. - Investors who purchased or sold Cepton common stock during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [4]. Group 3: Allegations Against Cepton - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations, including failing to disclose a credible third-party bid that valued Cepton at more than double the Koito Acquisition [5]. - The Board of Directors is accused of not adequately exploring this offer and failing to disclose its terms, depriving shareholders of the opportunity to make an informed decision regarding the Koito Acquisition [5].

Core Viewpoint - A class action lawsuit has been filed against Six Flags Entertainment Corporation, alleging that the company and its executives misled investors regarding the financial health and operational needs of the company prior to its merger with Cedar Fair, L.P. [1][3] Summary by Sections Lawsuit Details - The lawsuit is titled "City of Livonia Employees' Retirement System v. Six Flags Entertainment Corporation" and was filed in the Northern District of Ohio [1]. - Investors who purchased Six Flags stock in connection with the merger have until January 5, 2026, to seek lead plaintiff status [1]. Allegations Against Six Flags - The registration statement for the merger allegedly failed to disclose that Legacy Six Flags had chronic underinvestment and required significant additional capital to maintain its competitive position in the amusement park market [3]. - After becoming CEO in November 2021, Selim Bassoul reduced the employee headcount to cut costs, which negatively impacted operational competence and guest experience [3]. Stock Performance - On the merger closing date, July 1, 2024, Six Flags stock was trading above $55 per share, but it subsequently fell to as low as $20 per share, representing a decline of nearly 64% [4].

Core Viewpoint - Rosen Law Firm is encouraging KBR, Inc. investors who purchased securities between May 6, 2025, and June 19, 2025, to secure legal counsel before the November 18, 2025, deadline for a securities class action lawsuit [1][5]. Group 1: Class Action Details - Investors who purchased KBR securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 18, 2025 [3][6]. - The lawsuit alleges that KBR's defendants made materially false and misleading statements regarding the company's operations and prospects, particularly concerning the Global Household Goods Contract with the U.S. Department of Defense [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked highly for its number of securities class action settlements and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Points - Rosen Law Firm is reminding investors of Sina Corporation about the November 18, 2025 deadline to join a securities class action related to the merger that occurred between October 13, 2020, and March 22, 2021 [1][2] Group 1: Class Action Details - Investors who sold ordinary shares during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by November 18, 2025 [3] - The lawsuit alleges that defendants created a fraudulent scheme to depress the value of Sina's shares to avoid paying a fair price during the merger [5] Group 2: Allegations Against Defendants - The defendants are accused of misrepresenting and omitting material information in Sina's proxy materials, which were necessary for shareholders to make informed decisions regarding the merger [5] - Specific allegations include the concealment of the true value of Sina's investment in TuSimple and that the merger offer of $43.30 per share significantly undervalued Sina's ordinary shares [5] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and being ranked No. 1 for securities class action settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]

Core Viewpoint - Rosen Law Firm is encouraging investors of Molina Healthcare, Inc. to secure legal counsel before the December 2, 2025 deadline for a securities class action lawsuit related to undisclosed adverse facts affecting the company's financial guidance and operations [1][5]. Group 1: Class Action Details - The class action pertains to Molina securities purchased between February 5, 2025, and July 23, 2025, with a lead plaintiff deadline set for December 2, 2025 [1][2]. - Investors who purchased Molina securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][3]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. Group 2: Allegations Against Molina - The lawsuit alleges that Molina failed to disclose material adverse facts regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [5]. - It is claimed that Molina's near-term growth relied on a lack of utilization of various health services, which could lead to a substantial cut in financial guidance for fiscal year 2025 [5]. - The lawsuit asserts that positive statements made by Molina regarding its business and operations were materially misleading and lacked a reasonable basis [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in representing clients in such cases [4].

Core Viewpoint - Hormel Foods Corporation is facing potential securities claims due to allegations of issuing materially misleading business information, leading to a significant drop in stock price following negative earnings forecasts and operational challenges [1][3]. Group 1: Company Performance and Challenges - On October 29, 2025, Hormel Foods announced a cut in its earnings forecast, citing price pressures, bird flu, and a fire at its Arkansas peanut butter production facility as contributing factors [3]. - Following this announcement, Hormel Foods' stock experienced a decline of 9.1% on the same day [3]. Group 2: Legal Actions and Investor Rights - The Rosen Law Firm is investigating potential securities claims on behalf of Hormel shareholders and is preparing a class action to seek recovery of investor losses without upfront costs [1][2]. - Investors who purchased Hormel securities may be eligible for compensation and are encouraged to join the prospective class action [2]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and being recognized for its success in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of Jasper Therapeutics, Inc. to secure legal counsel before the November 18, 2025 deadline for a securities class action lawsuit related to the company's alleged misleading statements and failures in compliance with manufacturing regulations [1][5]. Group 1: Class Action Details - Investors who purchased Jasper Therapeutics securities between November 30, 2023, and July 3, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 18, 2025 [3]. - The lawsuit claims that Jasper Therapeutics made false and misleading statements regarding its manufacturing controls and the implications for its product, briquilimab, which could negatively impact its regulatory and commercial prospects [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including a notable settlement against a Chinese company and significant recoveries for investors in previous years [4]. Group 3: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. - It is important to note that no class has been certified yet, and investors may choose to remain absent or select their own counsel [7].

Core Points - The CarMax class action lawsuit has been initiated against CarMax, Inc. and certain executives for alleged violations of the Securities Exchange Act of 1934 during the class period from June 20, 2025, to November 5, 2025 [1][3] - Investors who suffered losses during this period can seek to be appointed as lead plaintiff by January 2, 2026 [1][6] Allegations - The lawsuit claims that CarMax recklessly overstated its growth prospects, attributing earlier growth in fiscal year 2026 to temporary factors related to customer behavior influenced by tariff speculation [3] - On September 25, 2025, CarMax reported a 5.4% decrease in retail unit sales and a 6.3% decrease in comparable store unit sales, with net earnings per diluted share dropping to $0.64 from $0.85 year-over-year, leading to a 20% drop in share price [4] - Following the termination of CEO William D. Nash on November 4, 2025, and the expectation of weak third-quarter sales, CarMax shares fell over 24% [5] Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased CarMax securities during the class period to seek lead plaintiff status, which involves directing the lawsuit on behalf of all class members [6] About the Law Firm - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [7]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Agilon Health, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation Details - The investigation is prompted by claims that Agilon Health may have misled investors regarding its business performance [1]. - Shareholders who purchased Agilon Health securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. Group 2: Company Performance - On August 4, 2025, Agilon Health reported its second quarter results, indicating that industry headwinds were more severe than previously anticipated [3]. - Following the announcement, Agilon Health's stock experienced a significant decline of 51.5% on August 5, 2025, and the company suspended its full-year 2025 financial guidance [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms in this area since 2013 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - SOL Strategies Inc. has refiled its interim unaudited condensed financial statements for the three and nine months ended June 30, 2025 and 2024 to correct errors identified by its auditor [1][2]. Financial Statements Summary - The refiled Q3 Financial Statements include a reclassification of $23,588,748 of convertible debentures from long-term to current debt [6]. - A reallocation of $1,414,943 of convertible debentures was made, with $1,414,943 classified as equity within reserves and $5,625,273 classified as a deferred tax liability [6]. - The profit and loss statement was impacted by $20,156 due to accretion changes resulting from the restatements [6]. - The company has retrospectively recognized its August 5, 2025 share consolidation, restating all common shares and per share amounts to reflect this change [6]. Company Overview - SOL Strategies Inc. is a Canadian investment company focused on the Solana blockchain ecosystem, providing strategic investments and infrastructure solutions for decentralized applications [3].